Basic Information
Basic information for UCA1-216-25aa
Peptide Name UCA1-216-25aa
Genome Position chr19:15834822-15834896[+]
Species Human
Peptide Sequence MAIPACFQAGFIRSSGPSSLKTCRL
Peptide Length 25
Unique No (UCA1-201-25aa,UCA1-202-25aa,UCA1-203-25aa,UCA1-204-25aa,UCA1-205-25aa,UCA1-207-25aa,UCA1-208-25aa,UCA1-210-25aa,UCA1-211-25aa,UCA1-212-25aa,UCA1-213-25aa,UCA1-214-25aa,UCA1-215-25aa,UCA1-218-25aa,UCA1-220-25aa,UCA1-221-25aa,UCA1-222-25aa,UCA1-223-25aa,UCA1-224-25aa,UCA1-225-25aa,UCA1-226-25aa,UCA1-227-25aa,UCA1-229-25aa,UCA1-232-25aa,UCA1-233-25aa,UCA1-234-25aa,UCA1-235-25aa,UCA1-237-25aa,UCA1-238-25aa,UCA1-240-25aa,UCA1-243-25aa,UCA1-244-25aa)
Grand Average of Hydropathicity 0.408
Relative Molecular Mass 3074.52
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000644567;UCA1-216
Transcript Length 2627
Coding Ability 0.3955
DNA Sequence Corresponding to Peptide ATGGCCATCCCAGCATGCTTCCAAGCAGGCTTCATCCGTTCCTCTGGACCCTCATCTCTTAAGACCTGCCGCCTA
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :